Yoko Tsukita

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yoko Tsukita, Masataka Taguri, Yasushi Goto, Yukio Hosomi, Tomonori Mizutani, Kageaki Watanabe, Kiyotaka Yoh, Satoshi Takahashi, Kaoru Kubota, Hideo Kunitoh
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial). Japanese journal of clinical oncology (2024)
Yoko Tsukita, Masataka Taguri, Yasushi Goto, Yukio Hosomi, Tomonori Mizutani, Kageaki Watanabe, Kiyotaka Yoh, Satoshi Takahashi, Kaoru Kubota, Hideo Kunitoh
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial). Japanese journal of clinical oncology 54 (6) (2024)
Yoko Tsukita, Masataka Taguri, Yasushi Goto, Yukio Hosomi, Tomonori Mizutani, Kageaki Watanabe, Kiyotaka Yoh, Satoshi Takahashi, Kaoru Kubota, Hideo Kunitoh
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial). Japanese journal of clinical oncology 54 (6) (2024)
Yoko Tsukita, Akira Inoue
First-line therapy in non-small cell lung cancer patients with EGFR activating mutations: a consideration of the clinical position of osimertinib based on the subset of Japanese patients in the FLAURA study. Japanese journal of clinical oncology (2022)